The conversation between mother and doctor should include these specific study findings, the formulation distinction, and a plan for monitoring both maternal nutrition and infant development
That said, if medication nonadherence was a major factor for the blunted glycemic outcomes, the question remains why GLP-1 analog therapy did mediate significant weight loss, especially in women and SSRI users
Weight gain can be caused by underlying hormonal disorders such as: Hypothyroidism PCOS Cushing syndrome Insulin resistance Growth hormone deficiency Rare endocrine conditions An endocrinologist can identify these causes and create a personalized, evidence-based treatment plan
Compared to dual GIP/GLP-1 agonists such as ZepBound, Wegovy may produce slightly slower or less dramatic results in some patients, but it remains one of the most reliable and broadly effective agents available
But states may remain reluctant to offer the expensive drugs for obesity, because Medicaid recipients frequently churn on and off the coverage as their income changes